Care Navigator Support for Type 2 Diabetes
(AURORA Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The study proposes to rigorously evaluate a proactive, culturally responsive care navigator intervention targeting younger-onset Latinx individuals with a new T2D diagnosis (AURORA \[Active Outreach to Younger Latinx\]) within Kaiser Permanente Northern California (KPNC).
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
Is the Care Navigator Support for Type 2 Diabetes safe for humans?
The research does not provide specific safety data for the Care Navigator Support for Type 2 Diabetes or its related programs like AURORA Care Strategy. However, similar navigator programs have been used in healthcare settings to improve patient outcomes, suggesting they are generally considered safe.12345
What makes the AURORA Care Strategy treatment unique for managing Type 2 Diabetes?
What data supports the effectiveness of the AURORA Care Strategy treatment for Type 2 Diabetes?
Research shows that culturally tailored diabetes self-management education, which includes coaching and navigator programs, is effective in improving diabetes knowledge and health outcomes among Latinos. Additionally, using health information technology tools and patient navigators can help reduce healthcare disparities in this population.4591011
Who Is on the Research Team?
Anjali Gopalan, MD, MS
Principal Investigator
Kaiser Permanente
Are You a Good Fit for This Trial?
This trial is for younger Latinx adults aged between 20 and 45 who are members of Kaiser Permanente Northern California, have been newly diagnosed with Type 2 Diabetes in the last 1-8 months, and have an HbA1c level of at least 8%. They must be proficient in English or Spanish. Pregnant women and individuals with Type 1 Diabetes cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the AURORA Care Strategy, including three telemedicine visits tailored to Latinx adults with early onset type 2 diabetes
Follow-up
Participants are monitored for changes in HbA1c and other diabetes-related outcomes
What Are the Treatments Tested in This Trial?
Interventions
- AURORA Care Strategy
AURORA Care Strategy is already approved in United States for the following indications:
Find a Clinic Near You
Who Is Running the Clinical Trial?
Kaiser Permanente
Lead Sponsor